- €78.98m
- €56.71m
- €189.28m
- 55
- 53
- 60
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 238 | 143 | 155 | 173 | 189 |
Cost of Revenue | |||||
Gross Profit | 29.2 | 11.6 | 19.1 | 14.7 | 16.8 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 150 | 162 | 140 | 205 | 200 |
Operating Profit | 87.9 | -18.8 | 15.2 | -32.3 | -10.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 81.9 | -19.3 | 14.6 | -33.2 | -11.3 |
Provision for Income Taxes | |||||
Net Income After Taxes | 73.5 | -19.9 | 9.85 | -33.1 | -16.4 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 73.6 | -19.9 | 9.71 | -33.3 | -17.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 73.6 | -19.9 | 9.71 | -33.3 | -17.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.023 | -0.16 | -0.101 | -0.163 | -0.125 |
Dividends per Share |